IL6 and metabolic dysfunction-associated steatohepatitis: We observed that evodiamine did not markedly influence the ALT, AST of NASH rats, but significantly reduced the contents of hepatic IL-1β, IL-6, and TNF-α by 27.82%, 24.76%, and 29.72%, respectively.